Form 4: Acadia Healthcare Executive Receives Stock Grant
Insider Transaction Disclosure
Brian Farley, EVP, CLAO and Secretary of Acadia Healthcare, was granted 37,510 shares of common stock.
Summary
- Brian Farley, EVP, CLAO and Secretary of Acadia Healthcare Company, Inc. (ACHC), acquired 37,510 shares of common stock.
- The transaction occurred on April 28, 2026.
- The shares were acquired at a price of $0, representing a stock grant.
- Following this transaction, the reporting person's total beneficial ownership is 144,185 shares.
- The granted shares are subject to a 3-year vesting schedule in equal annual installments starting April 10, 2027.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding executive compensation, which is neutral in terms of immediate market impact.
Positives
- Increased equity alignment between the executive and shareholders.
- Retention of key leadership personnel through long-term equity incentives.
Negatives
- Potential for future dilution of existing shareholders upon the vesting and issuance of these shares.
Risks
- Market volatility affecting the value of equity-based compensation.
- Regulatory and operational risks inherent in the healthcare services industry.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of an executive equity grant.
Industry Context
StockSavvy.ai notes that equity grants to senior executives are standard practice in the healthcare sector to align management interests with long-term shareholder value creation.
Comparison to Industry Standards
- The use of 3-year vesting schedules for executive equity grants is consistent with standard corporate governance practices among large-cap healthcare providers.
- The grant size is commensurate with the role of an Executive Vice President and Chief Legal/Administrative Officer.
Stakeholder Impact
- Shareholders: Increased alignment of executive interests with company performance.
- Executive: Increased personal financial stake in the company's long-term success.
Next Steps
- Vesting of the first installment of shares on April 10, 2027.
Key Dates
| Date | Description |
|---|---|
| 04/28/2026 | Date of the stock grant transaction. |
| 04/30/2026 | Date the Form 4 was signed and filed. |
| 04/10/2027 | Commencement of the 3-year vesting period for the granted shares. |
Keywords
Acadia Healthcare, ACHC, Form 4, Insider Transaction, Equity Grant, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.